Global Connected Drug Delivery Devices Market Report 2022: A $2.95 Bn Market by 2027 – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

Global Connected Drug Delivery Devices Market Report 2022: A $2.95 Bn Market by 2027 – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com




Global Connected Drug Delivery Devices Market Report 2022: A $2.95 Bn Market by 2027 – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global connected drug delivery devices market reached a value of US$ 490.9 Million in 2021. Looking forward, the market to reach US$ 2,951.5 Million by 2027, exhibiting a CAGR of 34.85% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Connected drug delivery devices are smart wireless electronic systems used to support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors and monitoring tools to provide instant feedback and education tools for personalized patient care. They are convenient and save costs associated with clinic-based treatment.

Consequently, connected drug delivery devices are widely used in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, multiple sclerosis, clinically isolated syndrome, chronic obstructive pulmonary disease (COPD), and liver and renal transplant recipients.

The rapidly increasing cost of medical management and the rising need to improve patient treatment outcomes are among the main factors catalyzing the demand for connected drug delivery devices. Besides this, a shift in preferences towards home-based care is also stimulating the market growth.

Moreover, the rising number of individuals suffering from chronic diseases, along with the increasing emphasis on preventive care, is influencing the market positively. Furthermore, the widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR) is driving the market growth.

Apart from this, several manufacturers are offering devices that can connect to apps and programs, allow data transfer, enable automated tracking, and maximize patient safety. As they also provide access to real-time patient data, connected drug delivery devices are increasingly being utilized by biopharma companies for determining adherence improvement outcomes to regulators, payers, and patients.

Key Questions Answered in This Report:

  • How has the global connected drug delivery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global connected drug delivery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What is the breakup of the market based on the technology?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global connected drug delivery devices market and who are the key players?
  • What is the degree of competition in the industry?

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

  • Adherium Ltd.
  • BioCorp Production
  • Cohero Health Inc. (AptarGroup Inc.)
  • Elcam Medical ACS. Ltd
  • Findair Sp. z o. o.
  • Merck KGaA
  • Phillips Medisize (Molex LLC)
  • Propeller Health (Resmed Inc.)
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services Inc.

Key Market Segmentation:

Breakup by Product:

  • Connected Sensors
  • Connected Inhaler Sensors
  • Connectable Injection Sensors
  • Integrated Connected Devices
  • Connected Inhalation Devices
  • Connected Injection Devices

Breakup by End User:

  • Hospitals and Healthcare Providers
  • Homecare

Breakup by Technology:

  • Bluetooth
  • NFC
  • Others

Breakup by Region:

North America

  • United States
  • Canada

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

For more information about this report visit https://www.researchandmarkets.com/r/xf8zo1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900